A Study on the Effectiveness of AI-assisted Colonoscopy in Improving the Effect of Colonoscopy Training for Trainees

May 28, 2021 updated by: Renmin Hospital of Wuhan University

A Study on the Effectiveness of Artificial Intelligence-assisted Colonoscopy in Improving the Effect of Colonoscopy Training for Trainees

In this study,the AI-assisted system(EndoAngel)has the functions of reminding the ileocecal junction, withdrawal time, withdrawal speed, sliding lens, polyps in the field of vision, etc. These functions can improve the colonoscopy performance of novice physicians and assist the colonoscopy training。

Study Overview

Detailed Description

Colonoscopy is a key technique for detecting and diagnosing lesions of the lower digestive tract.High-quality endoscopy leads to better disease outcomes.However, the demand for endoscopy is high in China, and endoscopy is in short supply.A colonoscopy is a complex technical procedure that requires training and experience for maximal accuracy and safety.Therefore, it is of great significance to improve the colonoscopy ability of novice physicians and shorten the colonoscopy training time for solving the problems such as the lack and uneven distribution of digestive endoscopists and the substandard quality of endoscopy in China.

In recent years, deep learning algorithms have been continuously developed and increasingly mature.They have been gradually applied to the medical field. Computer vision is a science that studies how to make machines "see". Through deep learning, camera and computer can replace human eyes to carry out machine vision such as target recognition, tracking and measurement.Interdisciplinary cooperation in the field of medical imaging and computer vision is also one of the research hotspots in recent years. At present, it is mainly applied to the automatic identification and detection of lesions and quality control, and has achieved good results.

Our preliminary experiments have shown that deep learning has a high accuracy in endoscopic quality monitoring, which can effectively regulate doctors' operations, reduce blind spots and improve the quality of endoscopic examination.At the same time, it can also monitor the doctor's withdrawal time in real time and improve the detection rate of adenoma.In the previous work of our research group, we have successfully developed deep learning-based colonoscopy withdraw speed monitoring and intestinal cleanliness assessment, and verified the effectiveness of the AI-assisted system(EndoAngel) in improving the quality of gastroscopy and colonoscopy in clinical trials.

Based on the above rich foundation of preliminary work, as well as the huge demand in the field of colonoscopy training,By comparing the colonoscopy operation training for novices with and without EndoAngel assistance, we plan to compare the colonoscopy learning effect of novices with and without assistance, including skill results and cognitive level, to explore whether AI can promote the improvement of the colonoscopy operation training for novices.

Study Type

Interventional

Enrollment (Anticipated)

385

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Yu W Honggang, Doctor
  • Phone Number: +862788041911
  • Email: whdxrmyy@126.com

Study Contact Backup

Study Locations

    • Hubei
      • Wuhan, Hubei, China, 430000
        • Recruiting
        • Renmin Hospital of Wuhan University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Male or female ≥50 years old;
  2. Able to read, understand and sign informed consent
  3. The investigator believes that the subjects can understand the process of the clinical study, are willing and able to complete all study procedures and follow-up visits, and cooperate with the study procedures
  4. Patients requiring colonoscopy

Exclusion Criteria:

  1. Have drug or alcohol abuse or mental disorder in the last 5 years
  2. Pregnant or lactating women
  3. Patients with known multiple polyp syndrome;
  4. patients with known inflammatory bowel disease;
  5. known intestinal stenosis or space-occupying tumor;
  6. known colon obstruction or perforation;
  7. patients with a history of colorectal surgery;
  8. Patients with previous history of allergy to pre-used spasmolysis;
  9. Unable to perform biopsy and polyp removal due to coagulation disorders or oral anticoagulants;
  10. High risk diseases or other special conditions that the investigator considers the subject unsuitable for participation in the clinical trial.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: with AI-assisted system
The novice doctors are trained in colonoscopy with an artificial intelligence assisted system that can indicate abnormal lesions and the speed of withdrawal in real time, as well as feedback on the percentage of overspeed.
the artificial intelligence assistance system can indicate abnormal lesions and real-time withdrawal speed, and feedback the overspeed percentage.
No Intervention: without AI-assisted system
The novice doctors receive routine colonoscopy training without artificial intelligence assistance system and no special tips

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
CUSUM learning curve for colonoscopy (ACE scoring scale)
Time Frame: From the beginning to the end of colonoscopy training
From the beginning to the end of colonoscopy training
Average test score difference before and after training
Time Frame: From the beginning to the end of colonoscopy training
From the beginning to the end of colonoscopy training

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Average number of adenomas detected per patient
Time Frame: A month
The numerator is the total number of adenomas detected by colonoscopy, and the denominator is the total number of patients undergoing colonoscopy.
A month
The detection rate of large, small and micro polyps
Time Frame: A month
The numerator is the number of patients with large (≥10 mm), small (6-9 mm) and micro-small (≤5 mm) polyps detected by colonoscopy, and the denominator is the total number of patients receiving colonoscopy.
A month
The average number of large, small and micro polyps detected
Time Frame: A month
The numerator is the total number of large (≥10 mm), small (6-9 mm) and micro-small (≤5 mm) polyps detected by colonoscopy, and denominator is the total number of patients undergoing colonoscopy.
A month
The detection rate of large, small and micro adenomas
Time Frame: A month
The numerator is the number of patients with large (≥10 mm), small (6-9 mm) and micro-small (≤5 mm) adenomas detected by colonoscopy, and the denominator is the total number of patients receiving colonoscopy.
A month
The detection rate of adenoma in different sites
Time Frame: A month
The numerator is the number of patients with adenomas detected in the rectum, sigmoid colon, descending colon, transverse colon, ascending colon, ileocecal region and other sites during colonoscopy, and the denominator is the total number of patients receiving colonoscopy.
A month
The average number of adenomas detected in different sites
Time Frame: A month
The numerator is the total number of adenomas detected in the rectum, sigmoid colon, descending colon, transverse colon, ascending colon, ileocecal region and other sites during colonoscopy, and the denominator is the total number of patients undergoing colonoscopy.
A month
Detection rate of advanced adenoma
Time Frame: A month
The numerator is the number of patients diagnosed with advanced adenomas, and the denominator is the total number of patients undergoing colonoscopy,Advanced adenoma was defined as > 10mm adenoma, villous adenoma, tubular villous adenoma, high-grade intraepithelial neoplasia, and carcinoma.
A month
Polyp Detection Rate, PDR
Time Frame: A month
The numerator is the number of patients with polyps detected by colonoscopy, and the denominator is the total number of patients who underwent colonoscopy
A month
The average number of large, small and micro adenomas detected
Time Frame: A month
The numerator is the total number of large (≥10 mm), small (6-9 mm) and micro-small (≤5 mm) adenomas detected by colonoscopy, and denominator is the total number of patients undergoing colonoscopy.
A month
Number of missed return of the sliding endoscopy/number of successful return of the sliding endoscopy
Time Frame: A month
The numerator is the total number of sliding endoscopy during colonoscopy, and the denominator is the number of sliding endoscopy and successful return endoscopy during colonoscopy
A month
Real-time gut cleanliness score
Time Frame: During procedure
During colonoscopy, a real-time intestinal cleanliness score was given by EndoAngel based on the Boston-scale Boreal Preparation Score (BBPS).
During procedure
withdraw overspeed percentage
Time Frame: During procedure
The ratio of the overspeed duration to the total duration in the process of withdrawal.
During procedure
The withdraw time
Time Frame: During procedure
The time between colonoscopy arrival at ileocecal valve and colonoscopy exit from anus.
During procedure
Ratio of ileocecal reach
Time Frame: A month
For a period of time, the number of colonoscopies that failed to reach the ileocecal part accounted for the proportion of the total number of colonoscopies.
A month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yu w Honggang, Doctor, Renmin Hospital of Wuhan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

June 1, 2021

Primary Completion (Anticipated)

January 1, 2022

Study Completion (Anticipated)

February 1, 2022

Study Registration Dates

First Submitted

May 28, 2021

First Submitted That Met QC Criteria

May 28, 2021

First Posted (Actual)

June 3, 2021

Study Record Updates

Last Update Posted (Actual)

June 3, 2021

Last Update Submitted That Met QC Criteria

May 28, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EA-21-005

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Artificial Intelligence

Clinical Trials on artificial intelligence assistance system

3
Subscribe